Posted by Michael Wonder on 25 Feb 2019
Drug makers face Senate over drug pricing
24 February 2019 - Politicians to grill pharma executives over what is fast becoming a key election issue.
When seven executives from the world’s largest pharmaceutical companies appear in front of Congress this week, they will face a rare united front in US politics: both Republicans and Democrats agree that the price of drugs is just too high.
The six chief executives from Merck, Pfizer, AstraZeneca, AbbVie, Sanofi, and Bristol-Myers Squibb, plus an executive president from Johnson & Johnson, will face tough questions on Tuesday on what is fast becoming a key election issue for 2020.
